NAMPT and Obesity: The same doses of genistein reduced the levels of visfatin at six and twelve months, which explained the reduced fat metabolism; it should be noted that higher plasma visfatin concentrations were detected in a person with overweight/obesity, suggesting its use as a promising indicator of obesity [53].